Hepatitis B vaccine freezing in the Indonesian cold chain: evidence and solutions

OBJECTIVES: To document and characterize freezing temperatures in the Indonesian vaccine cold chain and to evaluate the feasibility of changes designed to reduce the occurrence of freezing. METHODS: Data loggers were used to measure temperatures of shipments of hepatitis B vaccine from manufacturer...

Full description

Saved in:
Bibliographic Details
Main Authors: Nelson Carib M. (Author), Wibisono Hariadi (Author), Purwanto Hary (Author), Mansyur Isa (Author), Moniaga Vanda (Author), Widjaya Anton (Author)
Format: Book
Published: The World Health Organization, 2004-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_847b2a1a95b24241a943abd0081a3910
042 |a dc 
100 1 0 |a Nelson Carib M.  |e author 
700 1 0 |a Wibisono Hariadi  |e author 
700 1 0 |a Purwanto Hary  |e author 
700 1 0 |a Mansyur Isa  |e author 
700 1 0 |a Moniaga Vanda  |e author 
700 1 0 |a Widjaya Anton  |e author 
245 0 0 |a Hepatitis B vaccine freezing in the Indonesian cold chain: evidence and solutions 
260 |b The World Health Organization,   |c 2004-01-01T00:00:00Z. 
500 |a 0042-9686 
520 |a OBJECTIVES: To document and characterize freezing temperatures in the Indonesian vaccine cold chain and to evaluate the feasibility of changes designed to reduce the occurrence of freezing. METHODS: Data loggers were used to measure temperatures of shipments of hepatitis B vaccine from manufacturer to point of use. Baseline conditions and three intervention phases were monitored. During each of the intervention phases, vaccines were removed progressively from the standard 2-8 °C cold chain. FINDINGS: Freezing temperatures were recorded in 75% of baseline shipments. The highest rates of freezing occurred during transport from province to district, storage in district-level ice-lined refrigerators, and storage in refrigerators in health centres. Interventions reduced freezing, without excessive heat exposure. CONCLUSIONS: Inadvertent freezing of freeze-sensitive vaccines is widespread in Indonesia. Simple strategies exist to reduce freezing - for example, selective transport and storage of vaccines at ambient temperatures. The use of vaccine vial monitors reduces the risk associated with heat-damaged vaccines in these scenarios. Policy changes that allow limited storage of freeze-sensitive vaccines at temperatures >2-8 °C would enable flexible vaccine distribution strategies that could reduce vaccine freezing, reduce costs, and increase capacity. 
546 |a EN 
690 |a Hepatitis B vaccines 
690 |a Freezing 
690 |a Refrigeration 
690 |a Drug storage/methods 
690 |a Transportation 
690 |a Drug stability 
690 |a Child health services 
690 |a Indonesia 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n Bulletin of the World Health Organization, Vol 82, Iss 2, Pp 99-105 (2004) 
787 0 |n http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862004000200006 
787 0 |n https://doaj.org/toc/0042-9686 
856 4 1 |u https://doaj.org/article/847b2a1a95b24241a943abd0081a3910  |z Connect to this object online.